Photo of Erman Akkus taken from mn.uio.no
Mar 23, 2024, 14:45
Article summaries by Erman Akkus: BMI and cancer prognosis and billiary tract cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X/Twitter:
1. ”BMI, weight change, and cancer prognosis: a meta-analysis of 73 cohort studies ESMO Open.
Obesity vs. normal weight
- worse OS: breast cancer, glioblastoma;
- better OS: GI, lung and renal cancers;
Underweight vs. normal weight
- worse OS: breast, GI, lung, head and neck cancers
Weight loss vs. nonweight change
- worse OS: GI cancers
Keeping normal body weight before and after diagnosis of the cancer may be the best.”
Read further.
Source: Erman Akkus/X
2. ”Biliary Tract Cancers: French National Clinical Practice Guideline.
- Localized disease: surgery and adjuvant capecitabine.
- No neoadjuvant treatment is validated to date.
- Advanced disease: Cisplatin-gemcitabine-durvalumab.
- Early biomarker testing.
- Second line: FOLFOX.”
Read further.
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12